| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 09/11/1998 | WO1998039024A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | WO1998038994A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 09/11/1998 | WO1998038985A2 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998031704A3 Tachykinin antagonists |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862574A1 Metal complexes as cysteine protease inhibitors |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862449A1 Chemokine inhibitor |
| 09/09/1998 | EP0862424A1 Pharmaceutical compositions comprising flurbiprofen |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192732A CB2 receptor agonist compounds |
| 09/09/1998 | CN1192687A Bacterial inhibition with an oligosaccharide compound |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/07/1998 | CA2202345A1 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cox-2 |
| 09/03/1998 | WO1998038216A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037879A1 Nimesulide gel systems for topical use |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2279277A1 Nimesulide gel systems for topical use |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861251A1 Morpholine derivatives and their use as therapeutic agents |
| 09/02/1998 | EP0861243A1 Heterocyclic compounds as bradykinin antagonists |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | EP0861092A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
| 09/02/1998 | EP0861081A1 Use of epinastine in the treatment of pain |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192201A N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/02/1998 | CN1192156A Treatment of T cell mediated autoimmune disorders |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds |
| 09/02/1998 | CN1192144A 1H-4(5)-substituted imidazole derivatives |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |
| 09/02/1998 | CN1191737A Liniment Tongbining for cold-type arthralgia |
| 09/01/1998 | US5801256 Method for the synthesis of 8-C-β-D 2'-O-(E)-cinnamoyl!glycopyranosyl-2- 2-hydroxy!propyl-7-methoxy-5-methylchromone |
| 09/01/1998 | US5801227 Antibodies to CD40 |
| 09/01/1998 | US5801201 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801195 Immunotherapeutic aryl amides |
| 09/01/1998 | US5801165 Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids |
| 09/01/1998 | US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions |
| 09/01/1998 | US5801040 Nucleic acid coding for the human testicular angiotensin converting enzyme (ACE ) and its uses, especially for the in vitro screening for this enzyme in the organism |
| 09/01/1998 | US5800385 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 08/27/1998 | WO1998037224A1 Transgenically produced non-secreted proteins |
| 08/27/1998 | WO1998037217A1 A soluble vaccinia virus protein that binds chemokines |
| 08/27/1998 | WO1998037099A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/27/1998 | WO1998037094A2 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998037057A1 Preparation of acid amides and metallisation of compounds |
| 08/27/1998 | WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 08/27/1998 | WO1998036747A1 Pharmaceutical composition |
| 08/27/1998 | WO1998036728A2 Sustained analgesia achieved with buprenorphine |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | WO1998015295A3 Radiopharmaceuticals for imaging infection and inflammation |
| 08/27/1998 | WO1998006437A3 Compositions and methods for polynucleotide delivery |
| 08/27/1998 | CA2615918A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 08/27/1998 | CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 08/27/1998 | CA2281949A1 Transgenically produced non-secreted proteins |
| 08/27/1998 | CA2281893A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/27/1998 | CA2281059A1 Secreted proteins and polynucleotides encoding them |
| 08/26/1998 | EP0860506A1 Human protein kinase hYAKI (HOACF 72) |
| 08/26/1998 | EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes |